The University of Chicago Header Logo

Connection

Robert Rosenfield to Animals

This is a "connection" page, showing publications Robert Rosenfield has written about Animals.
Connection Strength

0.264
  1. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocr Rev. 2016 10; 37(5):467-520.
    View in: PubMed
    Score: 0.036
  2. Mutations of the hexose-6-phosphate dehydrogenase gene rarely cause hyperandrogenemic polycystic ovary syndrome. Steroids. 2011 Jan; 76(1-2):135-9.
    View in: PubMed
    Score: 0.024
  3. Evidence that obesity and androgens have independent and opposing effects on gonadotropin production from puberty to maturity. Brain Res. 2010 Dec 10; 1364:186-97.
    View in: PubMed
    Score: 0.024
  4. Molecular genetic and endocrine mechanisms of hair growth. Horm Res. 2003; 60(1):1-13.
    View in: PubMed
    Score: 0.014
  5. Sebaceous epithelial cell differentiation requires cyclic adenosine monophosphate generation. In Vitro Cell Dev Biol Anim. 2002 Jan; 38(1):54-7.
    View in: PubMed
    Score: 0.013
  6. Limited cooperation between peroxisome proliferator-activated receptors and retinoid X receptor agonists in sebocyte growth and development. Mol Genet Metab. 2001 Nov; 74(3):362-9.
    View in: PubMed
    Score: 0.013
  7. The role of specific retinoid receptors in sebocyte growth and differentiation in culture. J Invest Dermatol. 2000 Feb; 114(2):349-53.
    View in: PubMed
    Score: 0.012
  8. Peroxisome proliferator-activated receptors and skin development. Horm Res. 2000; 54(5-6):269-74.
    View in: PubMed
    Score: 0.012
  9. Growth hormone and insulin-like growth factors have different effects on sebaceous cell growth and differentiation. Endocrinology. 1999 Sep; 140(9):4089-94.
    View in: PubMed
    Score: 0.011
  10. Rat preputial sebocyte differentiation involves peroxisome proliferator-activated receptors. J Invest Dermatol. 1999 Feb; 112(2):226-32.
    View in: PubMed
    Score: 0.011
  11. Mechanisms of androgen induction of sebocyte differentiation. Dermatology. 1998; 196(1):43-6.
    View in: PubMed
    Score: 0.010
  12. Preputial sebocyte 5alpha-reductase isoform specificity. Endocrinology. 1997 Oct; 138(10):4416-20.
    View in: PubMed
    Score: 0.010
  13. Androgen receptor expression in the preputial gland and its sebocytes. J Invest Dermatol. 1994 Nov; 103(5):721-5.
    View in: PubMed
    Score: 0.008
  14. Gonadotropin-releasing hormone agonist as a probe for the pathogenesis and diagnosis of ovarian hyperandrogenism. Ann N Y Acad Sci. 1993 May 28; 687:162-81.
    View in: PubMed
    Score: 0.007
  15. Growth of sebaceous cells in monolayer culture. In Vitro Cell Dev Biol. 1992 Feb; 28A(2):83-9.
    View in: PubMed
    Score: 0.007
  16. Cyclic AMP-receptor protein activity in rat preputial cells. J Invest Dermatol. 1991 Sep; 97(3):517-23.
    View in: PubMed
    Score: 0.006
  17. Insulin-like growth factor-I enhances luteinizing hormone binding to rat ovarian theca-interstitial cells. J Clin Invest. 1990 Aug; 86(2):560-5.
    View in: PubMed
    Score: 0.006
  18. Relationship of sebaceous cell stage to growth in culture. J Invest Dermatol. 1989 May; 92(5):751-4.
    View in: PubMed
    Score: 0.006
  19. KLF15 Is a transcriptional regulator of the human 17beta-hydroxysteroid dehydrogenase type 5 gene. A potential link between regulation of testosterone production and fat stores in women. J Clin Endocrinol Metab. 2009 Jul; 94(7):2594-601.
    View in: PubMed
    Score: 0.005
  20. Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells. Endocrinology. 1988 Aug; 123(2):733-9.
    View in: PubMed
    Score: 0.005
  21. Estradiol inhibition of pituitary luteinizing hormone release is antagonized by serum proteins. J Steroid Biochem. 1986 Sep; 25(3):309-14.
    View in: PubMed
    Score: 0.005
  22. The changing ratio of bioactive to immunoreactive luteinizing hormone (LH) through puberty principally reflects changing LH radioimmunoassay dose-response characteristics. J Clin Endocrinol Metab. 1985 Sep; 61(3):508-13.
    View in: PubMed
    Score: 0.004
  23. Direct inhibitory effect of estradiol on pituitary luteinizing hormone responsiveness to luteinizing hormone releasing hormone is specific and of rapid onset. Biol Reprod. 1984 Feb; 30(1):59-66.
    View in: PubMed
    Score: 0.004
  24. Experimental cryptorchidism in adult male rats: histological and hormonal sequelae. Anat Rec. 1977 Sep; 189(1):1-27.
    View in: PubMed
    Score: 0.002
  25. Androgens and ovarian structure in constant oestrus. J Endocrinol. 1975 May; 65(2):283-4.
    View in: PubMed
    Score: 0.002
  26. Hypogonadism induced by a transplantable, prolactin-producing tumor in male rats: hormonal and morphological studies. Endocrinology. 1974 Oct; 95(4):991-8.
    View in: PubMed
    Score: 0.002
  27. Substitution of aspartic acid-686 by histidine or asparagine in the human androgen receptor leads to a functionally inactive protein with altered hormone-binding characteristics. Mol Endocrinol. 1991 Oct; 5(10):1562-9.
    View in: PubMed
    Score: 0.002
  28. Relationship of androgen action to androgen metabolism in isolated rat granulosa cells. J Steroid Biochem. 1980 Sep; 13(9):1015-9.
    View in: PubMed
    Score: 0.001
  29. Reduction of the potency of luteinizing hormone by estrogen. N Engl J Med. 1979 May 03; 300(18):1034-6.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.